Shares of NervGen Pharma (NASDAQ:NGEN – Get Free Report) have been given an average rating of “Moderate Buy” by the six brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, two have issued a buy recommendation and two […]